The history of Sildenafil presents a nuanced case for observers in the drug sector. While initially a blockbuster success, producing billions, the intellectual property expiration and the subsequent flood of cheaper versions have considerably changed revenue. This presents questions about the ongoing profitability of analogous therapeutic innova… Read More